Company news

Collegium Pharmaceutical, Inc. news in 2022

Collegium Pharmaceutical, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Appeals Court Affirms Validity of Collegium’s Belbuca® Patents

December 21, 2022

Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference

November 21, 2022

Collegium Reports Third Quarter 2022 Financial Results

November 2, 2022

Collegium to Report Third Quarter 2022 Financial Results on November 3, 2022

October 19, 2022

Collegium Announces 11 Poster Presentations at PAINWeek 2022 National Conference

August 29, 2022

Collegium Reports Second Quarter 2022 Financial Results

August 3, 2022

Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022

July 20, 2022

Collegium to Participate in H.C. Wainwright Global Investment Conference

May 16, 2022

Collegium Reports First Quarter 2022 Financial Results

May 9, 2022

Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results

April 25, 2022

Collegium to Participate in Upcoming Needham Healthcare Conference

April 6, 2022

Collegium Appoints Neil McFarlane to its Board of Directors

April 5, 2022

Collegium Provides 2022 Financial Guidance

April 4, 2022

Collegium Announces Master Settlement Agreement Resolving Pending Opioid-Related Litigation

March 29, 2022

Collegium Completes the Acquisition of BDSI

March 21, 2022

Collegium Reports Fourth Quarter and Full-Year 2021 Financial Results

February 23, 2022

Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio

February 13, 2022

Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2021 Financial Results

February 9, 2022

Calls in 2022

Decks in 2022